PT966533E - Factor neurotrófico iii dependente da actividade (adnf iii) - Google Patents
Factor neurotrófico iii dependente da actividade (adnf iii) Download PDFInfo
- Publication number
- PT966533E PT966533E PT98907407T PT98907407T PT966533E PT 966533 E PT966533 E PT 966533E PT 98907407 T PT98907407 T PT 98907407T PT 98907407 T PT98907407 T PT 98907407T PT 966533 E PT966533 E PT 966533E
- Authority
- PT
- Portugal
- Prior art keywords
- iii
- adnf iii
- adnf
- activity dependent
- neurotrophic factor
- Prior art date
Links
- 108010027834 activity-dependent neurotrophic factor Proteins 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 5
- 229920001184 polypeptide Polymers 0.000 abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 102100022385 Activity-dependent neuroprotector homeobox protein Human genes 0.000 abstract 2
- 101710170468 Activity-dependent neuroprotector homeobox protein Proteins 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 101710091045 Envelope protein Proteins 0.000 abstract 1
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 abstract 1
- HOKKHZGPKSLGJE-UHFFFAOYSA-N N-methyl-D-aspartic acid Natural products CNC(C(O)=O)CC(O)=O HOKKHZGPKSLGJE-UHFFFAOYSA-N 0.000 abstract 1
- 101710188315 Protein X Proteins 0.000 abstract 1
- 102100021696 Syncytin-1 Human genes 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000030833 cell death Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000003492 excitotoxic effect Effects 0.000 abstract 1
- 231100000063 excitotoxicity Toxicity 0.000 abstract 1
- 230000004770 neurodegeneration Effects 0.000 abstract 1
- 230000004776 neurological deficiency Effects 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- CFMYXEVWODSLAX-QOZOJKKESA-N tetrodotoxin Chemical compound O([C@@]([C@H]1O)(O)O[C@H]2[C@@]3(O)CO)[C@H]3[C@@H](O)[C@]11[C@H]2[C@@H](O)N=C(N)N1 CFMYXEVWODSLAX-QOZOJKKESA-N 0.000 abstract 1
- 229950010357 tetrodotoxin Drugs 0.000 abstract 1
- CFMYXEVWODSLAX-UHFFFAOYSA-N tetrodotoxin Natural products C12C(O)NC(=N)NC2(C2O)C(O)C3C(CO)(O)C1OC2(O)O3 CFMYXEVWODSLAX-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Psychiatry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Unknown Constitution (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Lock And Its Accessories (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3740497P | 1997-02-07 | 1997-02-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT966533E true PT966533E (pt) | 2010-01-26 |
Family
ID=21894162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98907407T PT966533E (pt) | 1997-02-07 | 1998-02-06 | Factor neurotrófico iii dependente da actividade (adnf iii) |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP2172478A3 (pt) |
| JP (1) | JP4649602B2 (pt) |
| AT (1) | ATE443141T1 (pt) |
| AU (1) | AU737406B2 (pt) |
| CA (1) | CA2279231C (pt) |
| DE (1) | DE69841160D1 (pt) |
| DK (1) | DK0966533T3 (pt) |
| ES (1) | ES2331595T3 (pt) |
| PT (1) | PT966533E (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090075900A1 (en) * | 2004-04-08 | 2009-03-19 | Sadakazu | Therapeutic agent for motor neuron disease |
| WO2006099739A1 (en) * | 2005-03-23 | 2006-09-28 | Ramot At Tel-Aviv University Ltd. | Use of adnf polypeptides for treating peripheral neurotoxicity |
| US8956859B1 (en) | 2010-08-13 | 2015-02-17 | Aviex Technologies Llc | Compositions and methods for determining successful immunization by one or more vaccines |
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
| EP4157338A4 (en) | 2020-05-26 | 2024-11-13 | TrueBinding, Inc. | METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3740497A (en) | 1971-06-29 | 1973-06-19 | G Daniell | Artificial line bridge subscriber dial long line equipment tester |
| US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4254082A (en) | 1978-06-12 | 1981-03-03 | Miles Laboratories, Inc. | Specific binding-adsorbent assay test means |
| US4391904A (en) | 1979-12-26 | 1983-07-05 | Syva Company | Test strip kits in immunoassays and compositions therein |
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| US4517288A (en) | 1981-01-23 | 1985-05-14 | American Hospital Supply Corp. | Solid phase system for ligand assay |
| US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
| CH652145A5 (de) | 1982-01-22 | 1985-10-31 | Sandoz Ag | Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen. |
| JPS58215453A (ja) | 1982-06-09 | 1983-12-14 | Toray Silicone Co Ltd | 室温硬化後塗装可能なオルガノポリシロキサン組成物 |
| US4716111A (en) | 1982-08-11 | 1987-12-29 | Trustees Of Boston University | Process for producing human antibodies |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4634666A (en) | 1984-01-06 | 1987-01-06 | The Board Of Trustees Of The Leland Stanford Junior University | Human-murine hybridoma fusion partner |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5169939A (en) | 1985-05-21 | 1992-12-08 | Massachusetts Institute Of Technology & Pres. & Fellows Of Harvard College | Chimeric antibodies |
| CA1291031C (en) | 1985-12-23 | 1991-10-22 | Nikolaas C.J. De Jaeger | Method for the detection of specific binding agents and their correspondingbindable substances |
| IL84285A (en) | 1986-10-27 | 1993-03-15 | Int Genetic Engineering | Chimeric antibody with specificity to human tumor antigen |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| US5001065A (en) | 1987-05-27 | 1991-03-19 | Cetus Corporation | Human cell line and triomas, antibodies, and transformants derived therefrom |
| US5202238A (en) | 1987-10-27 | 1993-04-13 | Oncogen | Production of chimeric antibodies by homologous recombination |
| US5204244A (en) | 1987-10-27 | 1993-04-20 | Oncogen | Production of chimeric antibodies by homologous recombination |
| US5231026A (en) | 1987-12-31 | 1993-07-27 | Tanox Biosystems, Inc. | DNA encoding murine-human chimeric antibodies specific for antigenic epitopes of IgE present on the extracellular segment of the membrane domain of membrane-bound IgE |
| US4975369A (en) | 1988-04-21 | 1990-12-04 | Eli Lilly And Company | Recombinant and chimeric KS1/4 antibodies directed against a human adenocarcinoma antigen |
| US5292867A (en) | 1988-11-16 | 1994-03-08 | Tanox Biosystems, Inc. | Chimeric monoclonal antibodies which bind to the extracellular segment of the membrane-bound domain of a human membrane-bound immunoglobulin |
| IL94872A (en) | 1989-06-30 | 1995-03-30 | Oncogen | Monoclonal or chimeric antibodies reactive with human carcinomas, recombinant proteins comprising their antigen binding region, pharmaceutical compositions and kits comprising said antibodies and methods for imaging human carcinoma using same |
| US5075431A (en) | 1989-07-26 | 1991-12-24 | City Of Hope | Chimeric anti-CEA antibody |
| US5081235A (en) | 1989-07-26 | 1992-01-14 | City Of Hope | Chimeric anti-cea antibody |
| CA2109098C (en) * | 1991-04-22 | 2005-08-09 | Douglas E. Brenneman | Activity-dependent neurotrophic factor |
| US6174862B1 (en) * | 1991-04-22 | 2001-01-16 | Ramot University Authority For Applied Research And Industrial Development, Ltd. | Neurotrophic peptides of activity dependent neurotrophic factor |
| GB9125979D0 (en) | 1991-12-06 | 1992-02-05 | Wellcome Found | Antibody |
| US5472693A (en) | 1993-02-16 | 1995-12-05 | The Dow Chemical Company | Family of anti-carcinoembryonic antigen chimeric antibodies |
| US5506132A (en) | 1993-07-28 | 1996-04-09 | Sandoz Pharmaceuticals Corporation | Human antibodies against varicella-zoster virus |
| US5426039A (en) | 1993-09-08 | 1995-06-20 | Bio-Rad Laboratories, Inc. | Direct molecular cloning of primer extended DNA containing an alkane diol |
-
1998
- 1998-02-06 PT PT98907407T patent/PT966533E/pt unknown
- 1998-02-06 EP EP09170287A patent/EP2172478A3/en not_active Withdrawn
- 1998-02-06 DE DE69841160T patent/DE69841160D1/de not_active Expired - Lifetime
- 1998-02-06 AT AT98907407T patent/ATE443141T1/de active
- 1998-02-06 CA CA2279231A patent/CA2279231C/en not_active Expired - Fee Related
- 1998-02-06 JP JP53498298A patent/JP4649602B2/ja not_active Expired - Fee Related
- 1998-02-06 DK DK98907407T patent/DK0966533T3/da active
- 1998-02-06 ES ES98907407T patent/ES2331595T3/es not_active Expired - Lifetime
- 1998-02-06 AU AU63222/98A patent/AU737406B2/en not_active Ceased
- 1998-02-06 EP EP98907407A patent/EP0966533B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0966533B1 (en) | 2009-09-16 |
| AU737406B2 (en) | 2001-08-16 |
| AU6322298A (en) | 1998-08-26 |
| JP2001522228A (ja) | 2001-11-13 |
| ATE443141T1 (de) | 2009-10-15 |
| DE69841160D1 (de) | 2009-10-29 |
| CA2279231C (en) | 2013-11-26 |
| EP2172478A3 (en) | 2010-07-28 |
| WO1998035042A2 (en) | 1998-08-13 |
| EP2172478A2 (en) | 2010-04-07 |
| WO1998035042A8 (en) | 2006-11-09 |
| CA2279231A1 (en) | 1998-08-13 |
| EP0966533A1 (en) | 1999-12-29 |
| ES2331595T3 (es) | 2010-01-08 |
| DK0966533T3 (da) | 2010-01-04 |
| JP4649602B2 (ja) | 2011-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2000027875A3 (en) | Activity dependent neurotrophic factor iii (adnf iii) | |
| EP1439230A3 (en) | Human transmembrane protein TMP-2 gene | |
| EP0477971A3 (en) | Human cnp gene and precursor protein | |
| SI0917571T1 (en) | Agouti-related gene | |
| EP0994728A4 (en) | SPECIFIC, RECOMBINANT ANTIBODIES FOR THE TERMINI OF BETA AMYLOIDS, CODING DNA FOR THEM AND METHOD FOR THEIR USE | |
| EP0258411A4 (en) | DNA ENCODING STREPTAVIDINE, STREPTAVIDINE PRODUCED FROM IT, FUSED POLYPEPTIDES WITH AMINO ACID SEQUENCES FROM STREPTAVIDINE AND USES. | |
| WO1995021919A3 (en) | Protein having tpo activity | |
| WO2001038486A3 (en) | Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies | |
| WO1999053061A3 (en) | Tumor associated nucleic acids and uses therefor | |
| WO2001032910A3 (en) | 27 human secreted proteins | |
| WO2001012776A3 (en) | 18 human secreted proteins | |
| WO2000077026A8 (en) | 49 human secreted proteins | |
| WO2000015659A3 (en) | Stomach polypeptide zsig28 | |
| PT966533E (pt) | Factor neurotrófico iii dependente da actividade (adnf iii) | |
| WO1993017031A3 (en) | Nucleic acids encoding dystrophin-associated proteins | |
| WO2000063230A3 (en) | 49 human secreted proteins | |
| EP0773290A3 (en) | Novel LDL receptor analog protein and the gene coding therefor | |
| WO2000037613A3 (en) | Human akt-3 | |
| WO2001012775A3 (en) | 25 human secreted proteins | |
| WO2000058339A3 (en) | 50 human secreted proteins | |
| WO2000061624A8 (en) | 48 human secreted proteins | |
| WO2000043495A3 (en) | 33 human secreted proteins | |
| EP0832972A3 (en) | Cloning, expression and production of tasty peptides | |
| WO2001000662A3 (en) | The use of human fgh-8 polypeptides as neurotrophic agents | |
| WO2000061596A8 (en) | 50 human secreted proteins |